| scholarly article | Q13442814 |
| P50 | author | Monte Willis | Q38322683 |
| Kristine M Wadosky | Q63853890 | ||
| P2093 | author name string | Jessica E Rodríguez | |
| Bethany L Walton | |||
| Jin-na Min | |||
| Rebecca L Hite | |||
| P2860 | cites work | Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 | Q24293032 |
| The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice | Q24308721 | ||
| Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I | Q24558612 | ||
| Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3 | Q24673171 | ||
| Molecular basis of physiological heart growth: fundamental concepts and new players | Q27006868 | ||
| Molecular determinants for the recruitment of the ubiquitin-ligase MuRF-1 onto M-line titin | Q27643507 | ||
| The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling | Q28240232 | ||
| Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase | Q28240243 | ||
| A mammalian scaffold complex that selectively mediates MAP kinase activation | Q28281953 | ||
| Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale | Q28296128 | ||
| JNK is required for effector T-cell function but not for T-cell activation | Q28507174 | ||
| Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo | Q28511213 | ||
| MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress | Q28566574 | ||
| The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2 | Q28576814 | ||
| A cytoplasmic inhibitor of the JNK signal transduction pathway | Q28586970 | ||
| Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
| Role of insulin-like growth factors in embryonic and postnatal growth | Q29620034 | ||
| HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte | Q29620367 | ||
| Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human | Q33594290 | ||
| mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. | Q34229899 | ||
| The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling | Q34556111 | ||
| Muscle ring finger 1 mediates cardiac atrophy in vivo | Q34603561 | ||
| Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy | Q34736062 | ||
| The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun. | Q34760678 | ||
| Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models | Q35128706 | ||
| The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun | Q35458082 | ||
| Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment. | Q35543645 | ||
| Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function | Q35651124 | ||
| Back to your heart: ubiquitin proteasome system-regulated signal transduction | Q35803035 | ||
| Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins | Q36088932 | ||
| Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy | Q36322902 | ||
| Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. | Q36350821 | ||
| Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy | Q36358042 | ||
| Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway | Q36689649 | ||
| The fuzzy logic of physiological cardiac hypertrophy | Q36772114 | ||
| Myocardial AKT: the omnipresent nexus | Q36908289 | ||
| Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo | Q37057089 | ||
| Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise. | Q37164690 | ||
| Regulation of nicotinic acetylcholine receptor turnover by MuRF1 connects muscle activity to endo/lysosomal and atrophy pathways. | Q37179964 | ||
| MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets | Q37254485 | ||
| Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart? | Q37256933 | ||
| Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo | Q37332162 | ||
| Seek and destroy: the ubiquitin----proteasome system in cardiac disease. | Q37628822 | ||
| Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies | Q37741316 | ||
| The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? | Q37864469 | ||
| Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways | Q39750571 | ||
| The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation | Q40561467 | ||
| Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo | Q42750583 | ||
| Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch | Q46802020 | ||
| Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. | Q52545197 | ||
| Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. | Q54501477 | ||
| Defective T Cell Differentiation in the Absence of Jnk1 | Q58415329 | ||
| Growth hormone in exercise: comparison of physiological and pharmacological stimuli | Q67850954 | ||
| Genetics of mouse growth | Q77684683 | ||
| Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure | Q80044502 | ||
| Akt1 is required for physiological cardiac growth | Q83195147 | ||
| Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways | Q84734687 | ||
| P433 | issue | 7 | |
| P304 | page(s) | E723-39 | |
| P577 | publication date | 2014-01-14 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling | |
| P478 | volume | 306 |
| Q64057218 | Behavior of mice aboard the International Space Station |
| Q41644090 | Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis |
| Q38687425 | Diabetic cardiomyopathy: role of the E3 ubiquitin ligase |
| Q64972788 | Exercise during transition from compensated left ventricular hypertrophy to heart failure in aortic stenosis rats. |
| Q36582898 | Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1. |
| Q88664220 | Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo |
| Q39286941 | Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium |
| Q33717313 | MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo |
| Q33752237 | MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo. |
| Q35920226 | MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet |
| Q58706972 | Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice |
| Q57821113 | Proteasome biology and therapeutics in cardiac diseases |
| Q47192403 | Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis |
| Q49475135 | The E3 ubiquitin ligase MuRF2 attenuates LPS-induced macrophage activation by inhibiting production of inflammatory cytokines and migration |
| Q35911960 | The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination |
| Q39390991 | Ubiquitin Ligases and Posttranslational Regulation of Energy in the Heart: The Hand that Feeds |
| Q38663141 | Ubiquitin and ubiquitin-like proteins in cardiac disease and protection |
Search more.